Merck Market Cap 2006-2019 | MRK

Merck market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Merck market cap as of September 18, 2019 is $211.26B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $211.257B $42.294B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.221B 14.90
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $113.163B 21.89
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
AbbVie (ABBV) United States $105.859B 8.48
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bristol-Myers Squibb (BMY) United States $81.363B 11.54
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73